Lansley: Unions Make Use Of NHS Reforms To Have A Go At Administration
Sat, 01/21/2012 - 09:32 | 
Relations between the administration and health experts dropped to a new low after Andrew Lansley charged them of contradicting his NHS reforms as they were disappoint about cuts to their salary as well as pensions.
RNA drug maker Alnylam Pharmaceuticals Inc. announced that it will slash around 33 percent of its jobs with the aim to diminish costs and concentrate on its most hopeful drug candidates
Innate Pharma SA (IPH), a French drug maker, grew up the most in over two months in Paris trading after the firm said a discovery released in the journal Science may give rise to novel infection fighting medications.
Cubist Pharmaceuticals stated that its fourth quarter profit declined by more than half owing to expenditures linked to its acquirement of constipation drug manufacturer Adolor Corp.
Tags: Andrew Forced To Enhance NHS Negligence Funding; Amag Q4 Sales To Miss Anticipations
Andrew Lansley has been forced to offer up an added £185 million boost to assist the NHS fund legal battles because of growing numbers of carelessness claims.
Pain pills such as Percocet and Opana from Endo Pharmaceuticals may be in short supply after their fabrication plant was closed for production as well as quality concerns.
Ariad Pharmaceuticals’s scrip had its “outperform” ranking reaffirmed by research forecasters at Rodman & Renshaw in a report released on January 14.
Amag Pharmaceuticals stated that it anticipates its fourth quarter earnings to miss Street expectations, though it repeated its full year financial 2012 viewpoint.
